Sir David Cooksey will chair a review of the UK government's Bioscience Innovation and Growth Team report, Bioscience 2015, which will be a partnership with the BioIndustry Association (BIA). The announcement came at a BIA event, where Sir David was a speaker. He highlighted "some notable successes" but warned that "we have not made progress in financing of bioscience companies."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze